Building on their previous work delivering cancer drugs with nanoparticles, MIT and Harvard researchers have turned their attention to cardiovascular disease, designing new particles that can cling to damaged artery walls and slowly release medicine. The particles, dubbed “nanoburrs,” are coated with tiny protein fragments that allow them to stick to damaged arterial walls. Once… Continue reading